Cochlear LimitedASX: COH

CMD details, CNA leader change & FY27 guidance reaffirmed

· Issued by Cochlear Limited via ASX

Filed with ASX · · 134 pages · English

Summary by 6ix AI

Cochlear Limited's filing reports on its Capital Markets Day, reaffirming guidance for revenue growth and announcing the departure of its North America President. The company expects low single-digit sales growth and highlights the importance of developed market cochlear implants as a key growth driver. Cochlear also outlines strategies to expand access to treatment and improve referral pathways for adult cochlear implant candidates. The announcement emphasizes the need for increased awareness and medicalization of hearing loss to drive growth in the cochlear implant market.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

1 University Avenue Macquarie University NSW 2109 AUSTRALIA www.cochlear.com ASX Announcement 13 November 2026 Cochlear hosts Capital Markets Day, reaffirms FY27 guidance and announces departure of President, North America Cochlear Limited (ASX: COH) reaffirms its FY27 guidance of low single-digit...

Cochlear Limited on 6ix

In the deck

Earlier from Cochlear

Later from Cochlear

All Cochlear news releases